CURIS, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
CURIS, INC. (CRIS) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$716.79 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2015-02-24
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-12-31 was $0.00.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-09-30 was -$1.37M.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-06-30 was $557.25K, a 67.27% increase year-over-year.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-03-31 was $91.62K, a 69.59% decline year-over-year.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2014 was -$716.79K.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2013 was -$771.39K, a 134.18% decline from fiscal 2012.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2012 was $2.26M.
- CURIS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2011 was -$2.76M, a 578.70% decline from fiscal 2010.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$1.37M derived: sum of 2 quarters · filed 2015-02-24 | -$808.41K derived: sum of 3 quarters · filed 2015-02-24 | -$716.79K 10-K · filed 2015-02-24 | |
| 2014-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$808.41K derived: sum of 2 quarters · filed 2014-11-10 | -$716.79K 10-Q · filed 2014-11-10 | -$1.93M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-06-30 | $557.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $648.88K 10-Q · filed 2014-08-07 | -$560.80K derived: sum of 3 quarters · filed 2015-02-24 | -$1.63M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-03-31 | $91.62K 10-Q · filed 2014-05-09 | -$1.12M derived: sum of 2 quarters · filed 2015-02-24 | -$2.19M derived: sum of 3 quarters · filed 2015-02-24 | -$1.86M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$2.28M derived: sum of 2 quarters · filed 2015-02-24 | -$1.95M derived: sum of 3 quarters · filed 2015-02-24 | -$771.39K 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$1.07M 10-Q · filed 2013-11-12 | -$739.55K derived: sum of 2 quarters · filed 2013-11-12 | $438.29K 10-Q · filed 2014-11-10 | -$438.29K 10-Q · filed 2013-11-12 | $764.47K derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | $333.14K 10-Q · filed 2013-08-08 | $634.40K 10-Q · filed 2014-08-07 | $1.84M derived: sum of 3 quarters · filed 2014-05-09 | $3.38M derived: sum of 4 quarters · filed 2014-05-09 | |
| 2013-03-31 | $301.26K 10-Q · filed 2014-05-09 | $1.50M derived: sum of 2 quarters · filed 2014-05-09 | $3.05M derived: sum of 3 quarters · filed 2014-05-09 | $2.55M derived: sum of 4 quarters · filed 2014-05-09 | |
| 2012-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $2.74M derived: sum of 2 quarters · filed 2013-11-12 | $2.25M derived: sum of 3 quarters · filed 2013-11-12 | $2.26M 10-K · filed 2013-03-13 | |
| 2012-09-30 | $1.54M 10-Q · filed 2013-11-12 | $1.05M derived: sum of 2 quarters · filed 2013-11-12 | $1.05M 10-Q · filed 2013-11-12 | -$467.38K derived: sum of 4 quarters · filed 2013-11-12 | |
| 2012-06-30 | -$495.34K 10-Q · filed 2013-08-08 | -$487.40K 10-Q · filed 2013-08-08 | -$2.01M derived: sum of 3 quarters · filed 2013-08-08 | -$1.42M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2012-03-31 | $7.94K 10-Q · filed 2013-05-09 | -$1.51M derived: sum of 2 quarters · filed 2013-05-09 | -$926.63K derived: sum of 3 quarters · filed 2013-05-09 | -$1.25M derived: sum of 4 quarters · filed 2013-05-09 | |
| 2011-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | -$934.58K derived: sum of 2 quarters · filed 2013-03-13 | -$1.26M derived: sum of 3 quarters · filed 2013-03-13 | -$2.76M 10-K · filed 2013-03-13 | |
| 2011-09-30 | $587.18K 10-Q · filed 2012-11-06 | $266.74K derived: sum of 2 quarters · filed 2012-11-06 | -$1.23M 10-Q · filed 2012-11-06 | -$1.76M derived: sum of 4 quarters · filed 2013-03-13 | |
| 2011-06-30 | -$320.44K 10-Q · filed 2012-08-09 | -$1.82M 10-Q · filed 2012-08-09 | -$2.34M derived: sum of 3 quarters · filed 2013-03-13 | -$2.14M derived: sum of 4 quarters · filed 2013-03-13 | |
| 2011-03-31 | -$1.50M 10-Q · filed 2012-05-10 | -$2.02M derived: sum of 2 quarters · filed 2013-03-13 | -$1.82M derived: sum of 3 quarters · filed 2013-03-13 | ||
| 2010-12-31 | -$522.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | -$314.82K derived: sum of 2 quarters · filed 2013-03-13 | $575.81K 10-K · filed 2013-03-13 | ||
| 2010-09-30 | $207.50K 10-Q · filed 2011-10-31 | $1.10M 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |